Rob Johnston

Senior Technical Manager Drug Product @MoonLake Immunotherapeutics (NASDAQ: MLTX)

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2025 — Present

Senior Technical Manager Drug Product @MoonLake Immunotherapeutics (NASDAQ: MLTX)

View department →

Cambridge, GB

Led external fill-finish operations for sterile biologics. Responsibilities included end-to-end management of CDMO partnerships—from tech transfer through GMP manufacturing—to ensure high-quality, compliant, and timely drug product supply.I served as the primary technical liaison between MoonLake and its external manufacturing partners, driving process robustness, managing deviations and change controls, and supporting both clinical and commercial readiness. I focused on fostering strong collaborative relationships while maintaining rigorous quality and regulatory standards in a fast-paced biotech environment.

EDUCATION

2008 — 2011

University of East Anglia

BSc Hons, Cellular and Molecular Biochemistry; Plant and Microbe Biotechnology/Biochemistry

2011 — 2012

UCL Dept. of Biochemical Engineering

Master of Science (MSc), Biochemical Engineering

SKILLS

Computer HardwareLife SciencesBiotechnologyProtein PurificationFluid Flow and Mixing in BioprocessesCell CulturePlant BiologyMolecular BiologyBioprocess Synthesis and Process MappingCellular BiologyCommercialisation of Bioprocess ResearchDownstream ProcessingBiochemistryHeat and Mass Transfer in BioprocessesProtein ChemistryMicrosoft ExcelExcelStatisticsBlast FreezersChromatographyCell BiologyMinitabMicrobiologyLeachables and ExtractablesHplcWordMicrosoft WordScienceData AnalysisProcess ValidationReactor DesignBiofuelsControl Charts

ABOUT ROB JOHNSTON

New to the biotech entrepreneurship, and using my skills in bridging science, operations,…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Rob Johnston — Senior Technical Manager Drug Product at MoonLake Immunotherapeutics (NASDAQ: MLTX) in Cambridge, GB | Unifers